Business
/C O R R E C T I O N from Source -- Cipher Pharmaceuticals Inc./
/C O R R E C T I O N from Source -- Cipher Pharmaceuticals Inc./ Canada NewsWire ...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\n\n/C O R R E C T I O N from Source -- Cipher Pharmaceuticals Inc./\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMISSISSAUGA, ON, Oct. 17, 2017\n\n\n\nIn the news release, Notice of Cipher Pharmaceuticals Q2 2017 conference call, issued today at 09:32, please note that an error occurred in the headline which should read \"Notice of Cipher Pharmaceuticals Q3 2017 conference call\" not \"Notice of Cipher Pharmaceuticals Q2 2017 conference call\". The complete, corrected release follows:\n\nNotice of Cipher Pharmaceuticals Q3 2017 conference call\n\n\n\n\n\n\n\nMISSISSAUGA, ON, Oct. 17, 2017 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) (\"Cipher\" or \"the Company\") today announced the details of its Q3 2017 financial results conference call on Friday, November 3, 2017. \n\nQ3 2017 CONFERENCE CALL\n\nWHEN: Friday, November 3, 2017 at 8:30AM ET\n\nCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/2zbTEna. An archived replay of the webcast will be available for 90 days.\n\nAbout Cipher Pharmaceuticals Inc.\n\nCipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America.  For more information, visit www.cipherpharma.com.  \n\n\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\nView original content: http://www.newswire.ca/en/releases/archive/October2017/17/c2234.html\n\n\n\n\nCraig Armitage, LodeRock Advisors, (416) 347-8954, [email protected] CNW Group 2017\n","length":3168,"tagName":"div"}]